A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea
Clinical trial NCT01274897 · COMPLETED
Trial details
- NCT number
- NCT01274897
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-03-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.